NRS 585.410
Misbranded drugs and devices: False or misleading label.

585.370
Adulterated drugs and devices: Poisonous or insanitary ingredients. 585.380
Adulterated drugs and devices: Strength, quality or purity differing from official compendium. 585.390
Adulterated drugs and devices: Misrepresentation of strength, quality or purity if drug not in compendium. 585.400
Adulterated drugs and devices: Mixture with or substitution of another substance. 585.410
Misbranded drugs and devices: False or misleading label. 585.420
Misbranded drugs and devices: Contents of label on package. 585.430
Misbranded drugs and devices: Habit-forming substances. 585.440
Misbranded drugs and devices: Designation of drug by name not in compendium. 585.450
Misbranded drugs and devices: Directions for use and warnings on label. 585.460
Misbranded drugs and devices: Misleading container 585.470
Misbranded drugs and devices: Health-endangering when used as prescribed. 585.480
Misbranded drugs and devices: Drug containing amidopyrine, barbituric acid, cinchophen, dinitrophenol or sulfanilamide sold without prescription. 585.485
Restrictions on sale of dimethyl sulfoxide 585.490
Introduction or delivery for introduction of new drug into intrastate commerce before application is effective prohibited. 585.495
Licensing of manufacture of amygdalin and procaine hydrochloride 585.497
Assessment on gross receipts from sale of amygdalin and procaine hydrochloride.